These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 32860589)

  • 21. LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression.
    Tao W; Wang C; Zhu B; Zhang G; Pang D
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p.
    Dai D; Feng XD; Zhu WQ; Bao YN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10313-10323. PubMed ID: 31841186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
    Zhang Y; Wang F; Yu Y
    Oral Dis; 2023 May; 29(4):1505-1512. PubMed ID: 35152529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p.
    Zhao Y; Yao R
    Bioengineered; 2021 Dec; 12(1):8724-8737. PubMed ID: 34698001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
    Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
    [No Abstract]   [Full Text] [Related]  

  • 32. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
    Nagai H; Hasegawa S; Uchida F; Terabe T; Ishibashi Kanno N; Kato K; Yamagata K; Sakai S; Kawashiri S; Sato H; Yanagawa T; Bukawa H
    Int J Oncol; 2018 Mar; 52(3):841-850. PubMed ID: 29393341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
    Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
    Yan J; Xu H
    Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
    Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
    Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
    Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
    Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
    Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis.
    Pang L; Zhang Q; Wu Y; Yang Q; Zhang J; Liu Y; Li R
    Exp Biol Med (Maywood); 2021 Jan; 246(2):142-152. PubMed ID: 33023331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
    Wang X; Li F; Zhou X
    Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.